RecruitingNot ApplicableNCT06364527

Use of Aptar Digital Health's Respiratory Disease Management Platform for Asthma

Use of Aptar Digital Health's Respiratory Disease Management Platform for Asthma: A Pilot Study

Sponsor

CoheroHealth

Enrollment

118 participants

Start Date

Jul 18, 2024

Study Type

INTERVENTIONAL

Conditions

Asthma Chronic

Summary

The United Kingdom has a high prevalence of asthma (over 12%) and some of the worst health outcomes in Europe. The management of respiratory disease and associated patient outcomes has long been an area of focus and improvement for the National Health Service. With the advancement of digital health technology, there is the potential to transform patient care and improve outcomes. The Aptar Digital Health respiratory disease management platform, a digital therapeutic will be utilized to determine its value and how it supports: i) asthma patient engagement and facilitates communication between patients and providers to accelerate medication adherence; ii) asthma control through the use of the Asthma Control Questionnaire-5. In addition, spirometry and fractioned exhaled nitric oxide will be utilized during the study to validate and enhance current National Institute for Health and Care Excellence guidelines.

Eligibility

Min Age: 16 Years

Plain Language Summary

Simplified for easier understanding

This study tests a digital platform for people with moderate-to-severe uncontrolled asthma to see whether using a connected inhaler and app to track medication use and symptoms can help improve asthma control. **You may be eligible if...** - You are 16 or older - You have been diagnosed with asthma as your primary lung condition - You have moderate-to-severe uncontrolled asthma - You use an inhaled corticosteroid (ICS) or combination ICS/LABA inhaler - Your FeNO level (a measure of airway inflammation) is 45 or above - You are a non-smoker - You use a metered dose inhaler (MDI) or dry powder inhaler (DPI) compatible with the app device **You may NOT be eligible if...** - You smoke or use tobacco - Your asthma is well-controlled - Your primary lung diagnosis is something other than asthma - You are unwilling to use the app during the study Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEAptar Digital Health respiratory disease management platform

The Aptar Digital Health respiratory disease management platform is a digital health tool that combines a Healthcare Professional portal (BreatheSmart Connect) and an associated patient mobile application (BreatheSmart mobile application). The Aptar Digital Health respiratory disease management platform is intended to be used in conjunction with compatible connected sensor devices that track medication adherence and for some, technique.

Locations(1)

Guy's and St. Thomas' NHS Foundation Trust

London, England, United Kingdom

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06364527

Related Trials